DNA mutations shed in blood predicts response to immunotherapy in patients with cancer

A blood sample, or liquid biopsy, can reveal which patients will respond to checkpoint inhibitor-based immunotherapies, a first-of-its-kind study reports.

from Top Health News – ScienceDaily http://bit.ly/2yjhTDN
from Tumblr http://bit.ly/2xac8TM